Related references
Note: Only part of the references are listed.UN High-Level Meeting on antimicrobials-what do we need?
Ramanan Laxminarayan et al.
LANCET (2016)
Not all chemicals are created equal
CHEMICAL & ENGINEERING NEWS (2016)
Investigational new treatments for Clostridium difficile infection
Mattias E. Ivarsson et al.
DRUG DISCOVERY TODAY (2015)
Antibiotic effectiveness: Balancing conservation against innovation
Ramanan Laxminarayan
SCIENCE (2014)
Advances and strategies in discovery of new antibacterials for combating metabolically resting bacteria
Dirk Bald et al.
DRUG DISCOVERY TODAY (2013)
Antibiotics in the clinical pipeline in 2013
Mark S. Butler et al.
JOURNAL OF ANTIBIOTICS (2013)
Activated ClpP kills persisters and eradicates a chronic biofilm infection
B. P. Conlon et al.
NATURE (2013)
Anti-infective monoclonals step in where antimicrobials fail
Jeffrey L. Fox
NATURE BIOTECHNOLOGY (2013)
Medicines from microbiota
Bernat Olle
NATURE BIOTECHNOLOGY (2013)
Antimicrobial peptides stage a comeback
Jeffrey L. Fox
NATURE BIOTECHNOLOGY (2013)
Advances in the development of new tuberculosis drugs and treatment regimens
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Applying insights from biofilm biology to drug development - can a new approach be developed?
Thomas Bjarnsholt et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Bacteriocins - a viable alternative to antibiotics?
Paul D. Cotter et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Novel Antibiotics Targeting Respiratory ATP Synthesis in Gram-Positive Pathogenic Bacteria
Wendy Balemans et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The NIH's role in accelerating translational sciences
John C. Reed et al.
NATURE BIOTECHNOLOGY (2012)
Incentives aim to boost antibiotic development
Josh P. Roberts
NATURE BIOTECHNOLOGY (2012)
The antibiotic R&D pipeline: an update
Daniela Jabes
CURRENT OPINION IN MICROBIOLOGY (2011)
New Macrolides Essential to Treat CABP
Prabhavathi Fernandes et al.
Genetic Engineering & Biotechnology News (2011)
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
Linda Ejim et al.
NATURE CHEMICAL BIOLOGY (2011)
Quinolones: from antibiotics to autoinducers
Stephan Heeb et al.
FEMS MICROBIOLOGY REVIEWS (2011)
The importance of new companies for drug discovery: origins of a decade of new drugs
Robert Kneller
NATURE REVIEWS DRUG DISCOVERY (2010)
Achievements and new knowledge unraveled by metagenomic approaches
Carola Simon et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2009)
Strategies for the Discovery of New Natural Products by Genome Mining
Malek Zerikly et al.
CHEMBIOCHEM (2009)
Focus: Synergistetes
Philip Hugenholtz et al.
ENVIRONMENTAL MICROBIOLOGY (2009)
New Ways to Squash Superbugs
Christopher T. Walsh et al.
SCIENTIFIC AMERICAN (2009)
Molecular genetic mining of the Aspergillus secondary metabolome:: Discovery of the emericellamide biosynthetic pathway
Yi-Ming Chiang et al.
CHEMISTRY & BIOLOGY (2008)
Low hanging fruit in infectious disease drug development
Carl N. Kraus
CURRENT OPINION IN MICROBIOLOGY (2008)
Renaissance in antibacterial discovery from actinomycetes
Richard H. Baltz
CURRENT OPINION IN PHARMACOLOGY (2008)
Natural products as leads to potential drugs: An old process or the new hope for drug discovery?
David J. Newman
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Bacterial hosts for natural product production
Haoran Zhang et al.
MOLECULAR PHARMACEUTICS (2008)
Drugs from hidden bugs: their discovery via untapped resources
Fabrice Lefevre et al.
RESEARCH IN MICROBIOLOGY (2008)
Sweet antibiotics - the role of glycosidic residues in antibiotic and antitumor activity and their randomization
Vladimir Kren et al.
FEMS MICROBIOLOGY REVIEWS (2008)
Novel approaches to developing new antibiotics for bacterial infections
A. R. M. Coates et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Natural products as a screening resource
Alan L. Harvey
CURRENT OPINION IN CHEMICAL BIOLOGY (2007)
Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica
Daniel W. Udwary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Engineering the glycosylation of natural products in actinomycetes
Jose A. Salas et al.
TRENDS IN MICROBIOLOGY (2007)
Strategies to unravel the function of orphan biosynthesis pathways: recent examples and future prospects
Harald Gross
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2007)
Global diversity and distribution of macrofungi
Gregory M. Mueller et al.
BIODIVERSITY AND CONSERVATION (2007)
Type III polyketide synthase β-ketoacyl-ACP starter unit and ethylmalonyl-CoA extender unit selectivity discovered by Streptomyces coelicolor genome mining
Lijiang Song et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Geosmin biosynthesis in Streptomyces avermitilis.: Molecular cloning, expression, and mechanistic study of the germacradienol/geosmin synthase
David E. Cane et al.
JOURNAL OF ANTIBIOTICS (2006)
Genome mining in Streptomyces coelicolor:: Molecular cloning and characterization of a new sesquiterpene synthase
Xin Lin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Antibiotic resistance in bacteria and its future for novel antibiotic development
Hiroshi Yoneyama et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2006)
Natural products - The future scaffolds for novel antibiotics?
MS Butler et al.
BIOCHEMICAL PHARMACOLOGY (2006)
When will the genomics investment pay off for antibacterial discovery?
SD Mills
BIOCHEMICAL PHARMACOLOGY (2006)
Empirical antibacterial drug discovery - Foundation in natural products
SB Singh et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Antibiotic-producing ability by representatives of a newly discovered lineage of actinomycetes
E Busti et al.
MICROBIOLOGY-SGM (2006)
Dysregulation of bacterial proteolytic machinery by a new class of antibiotics
H Brötz-Oesterhelt et al.
NATURE MEDICINE (2005)
Can biotech deliver new antibiotics?
JF Barrett
CURRENT OPINION IN MICROBIOLOGY (2005)
Discovery of a new peptide natural product by Streptomyces coelicolor genome mining
S Lautru et al.
NATURE CHEMICAL BIOLOGY (2005)
A rising drug industry
AA Daemmrich et al.
CHEMICAL & ENGINEERING NEWS (2005)
Metagenomics and industrial applications
P Lorenz et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Isolation of novel bacteria and actinomycetes using soil-extract agar medium
T Hamaki et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2005)
Status of the microbial census
PD Schloss et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2004)
Antibacterial drug discovery in the 21st century
K Bush
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilis
H Ikeda et al.
NATURE BIOTECHNOLOGY (2003)
Fighting the clock - Pharmaceutical and biotechnology companies seek ways to reduce the time required to discover and develop medicines
KJ Watkins
CHEMICAL & ENGINEERING NEWS (2002)
Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials
AL Spoering et al.
JOURNAL OF BACTERIOLOGY (2001)